UMediC申请转主板上市|UMediC proposes to transfer listing from ACE to Main Market

UMediC申请转主板上市|UMediC proposes to transfer listing from ACE to Main Market

  (吉隆坡27日讯)UMediC集团(UMC,0256,创业板医疗保健组)申请转至主板上市。 该公司向大马股票交易所报备,由于盈利已符合要求,财务状况也稳健,加上公众持股权达32.70%,已超过至少25%的门槛,因此寻求转板上市。 UMediC集团是在2022年7月26日上市,转板活动则预计于2024年上半年完成。     – KLSE Screener  – www.klsescreener.com...
UMediC has prospective earnings growth over the next two years

UMediC has prospective earnings growth over the next two years

PETALING JAYA: Rakuten Trade Sdn Bhd has placed a “buy” call on medical device maker UMediC Group Bhd with a higher target price (TP) of 90 sen from 76 sen. In a report, the research house said the fast growing distributor of medical equipment and manufacturer of...
1 Year On Ace Market, UMediC Seeks Main Market Transfer

A surging first half for UMediC

  KUALA LUMPUR: UMediC Group Bhd (UMC) will see a surge in its public orders in the first half of 2024 (1HFY24) as the Ministry of Health (MoH) uses the budget allocated for the year to procure medical equipment.  Hong Leong Investment Bank Bhd (HLIB) said...
UMediC申请转主板上市|UMediC proposes to transfer listing from ACE to Main Market

UMediC Group is stable | 股价站稳基础 UMediC集团看涨

券商 :豐隆投银研究 投资建议 :短期买进 可买入价位:70-72-73仙 上行目标 :80-87-90仙 止损点 :67仙 闭市价 :73.5仙 (截至11月3日) 每股盈利 :3.5仙 (2024财年估计) 本益比 :21倍 (2024财年估计)   技术图显示,UMediC集团(UMC,0256,创业板医疗保健)目前在70至73仙之间建立稳定基础,豐隆投银研究指出,若成功突破78仙阻力点,将刺激该股朝向80仙、87仙和90仙;止损点为59仙。...